Clinical Trial Update: A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1) [Phase 2]

View source ↗

Summary

Phase 2 trial update for atezolizumab in locally advanced or metastatic urothelial/bladder cancer completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-21